Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Impact of diabetes against the future risk of developing gout.

Rodríguez G, Soriano LC, Choi HK.

Ann Rheum Dis. 2010 Dec;69(12):2090-4. doi: 10.1136/ard.2010.130013. Epub 2010 Jun 22.

2.

Menopause, postmenopausal hormone use and risk of incident gout.

Hak AE, Curhan GC, Grodstein F, Choi HK.

Ann Rheum Dis. 2010 Jul;69(7):1305-9. doi: 10.1136/ard.2009.109884. Epub 2009 Jul 9.

3.

Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.

Elliot AJ, Cross KW, Fleming DM.

Ann Rheum Dis. 2009 Nov;68(11):1728-33. doi: 10.1136/ard.2008.096693. Epub 2008 Nov 24.

PMID:
19029167
4.
5.

Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey.

Choi HK, Ford ES.

Rheumatology (Oxford). 2008 May;47(5):713-7. doi: 10.1093/rheumatology/ken066. Epub 2008 Apr 5.

PMID:
18390895
6.

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.

Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G.

Ann Rheum Dis. 2008 Jul;67(7):960-6. Epub 2007 Nov 2.

7.

Gout and risk of Parkinson disease: a prospective study.

Alonso A, Rodríguez LA, Logroscino G, Hernán MA.

Neurology. 2007 Oct 23;69(17):1696-700.

PMID:
17954784
8.

Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.

Roddy E, Zhang W, Doherty M.

Ann Rheum Dis. 2007 Oct;66(10):1311-5. Epub 2007 May 15.

9.
10.

Gout, diuretics and the kidney.

Pascual E, Perdiguero M.

Ann Rheum Dis. 2006 Aug;65(8):981-2. No abstract available.

11.

Epidemiology, risk factors, and lifestyle modifications for gout.

Saag KG, Choi H.

Arthritis Res Ther. 2006;8 Suppl 1:S2. Epub 2006 Apr 12. Review.

12.

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Ann Rheum Dis. 2006 Oct;65(10):1312-24. Epub 2006 May 17. Review.

13.

Sex differences in gout epidemiology: evaluation and treatment.

Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG.

Ann Rheum Dis. 2006 Oct;65(10):1368-72. Epub 2006 Apr 27.

14.

Epidemiology of hyperuricemia and gout.

Luk AJ, Simkin PA.

Am J Manag Care. 2005 Nov;11(15 Suppl):S435-42; quiz S465-8. Review.

15.

Gout, not induced by diuretics? A case-control study from primary care.

Janssens HJ, van de Lisdonk EH, Janssen M, van den Hoogen HJ, Verbeek AL.

Ann Rheum Dis. 2006 Aug;65(8):1080-3. Epub 2005 Nov 16.

16.

Pathogenesis of gout.

Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society.

Ann Intern Med. 2005 Oct 4;143(7):499-516. Review. No abstract available.

PMID:
16204163
17.

Gout: epidemiology and lifestyle choices.

Choi HK, Curhan G.

Curr Opin Rheumatol. 2005 May;17(3):341-5. Review.

PMID:
15838248
18.

Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.

Choi HK, Atkinson K, Karlson EW, Curhan G.

Arch Intern Med. 2005 Apr 11;165(7):742-8.

PMID:
15824292
19.

Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG.

Ann Rheum Dis. 2005 Feb;64(2):267-72.

20.

Feasibility study and methodology to create a quality-evaluated database of primary care data.

Bourke A, Dattani H, Robinson M.

Inform Prim Care. 2004;12(3):171-7.

Supplemental Content

Support Center